Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures

Pancreatic ductal adenocarcinoma (PDAC) is associated with high mortality and will become the second most common cause of cancer-associated mortality by 2030. The poor prognosis arises from a lack of sensitive biomarkers, limited therapeutic options, and the astonishingly high recurrence rate after...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Lukas M., Lagies, Simon, Klar, Rhena F. U., Hussung, Saskia, Fritsch, Ralph M., Kammerer, Bernd, Wittel, Uwe A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352957/
https://www.ncbi.nlm.nih.gov/pubmed/32492856
http://dx.doi.org/10.3390/cancers12061440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352957/
https://www.ncbi.nlm.nih.gov/pubmed/32492856
http://dx.doi.org/10.3390/cancers12061440

Ejemplares similares